Traditional cardiac pacemakers are implanted surgically just under the skin in the chest area. They are connected to the heart with thin insulated wires called leads that are threaded through veins into the heart chambers. Leads help deliver electrical pulses from the pacemaker to regulate abnormal heart rhythms. While pacemakers with leads have been greatly improving patient's lives for decades, the use of leads also introduces some risks. Over time, the leads can fracture or become dislodged, requiring additional medical procedures to repair or replace them. Pacemaker leads have also been associated with an increased risk of infection that can be serious and even life-threatening in some cases.

The Development of Leadless Pacemaker Technology

To address some of the limitations of traditional pacemaker systems, researchers have been developing Leadless Pacemakers technology. The first FDA-approved leadless pacemaker was Medtronic's Nanostim pacemaker, introduced commercially in 2016.

Get More Insights On-Leadless Pacemakers Market